A RAPID STABILITY INDICATING HPLC-METHOD FOR DETERMINATION OF NORETHISTERONE ACETATE IN PLASMA, TABLETS AND IN A MIXTURE WITH OTHER STEROIDS
Keywords:
Norethisterone acetate, Stability indicating method, Quantitation, PlasmaAbstract
Objectives: This study reports about a simple, rapid and accurate, routine-HPLC method for quantification of Norethisterone acetate (NA) in bulk powder, tablets and plasma.
Methods: The chromatographic separation is carried out using isocratic binary mobile phase consisting of acetonitrile (ACN) and water (H2O) in the ratio of 55: 45 at the flow rate of 1 mLmin-1 and 40 °C. A diode array detector is used at 240 nm for detection.
Results: The elution time of NA is found to be 2.946±0.01 minutes. The method is validated for system suitability, linearity, precision, limits of detection and quantitation, specificity, stability and robustness. The robustness study is done for small changes in temperature, flow rate, the wavelength of detection, mobile phase content of ACN and injection volume. Stability tests are done through exposure of the analyte solution for four different stress conditions: Reflux with 1N hydrochloric acid (HCl), reflux with 1N sodium hydroxide (NaOH), reflux with 30% hydrogen peroxide (H2O2) and exposure to ultraviolet radiation (UV) radiation. The limits of detection and quantitation are 0.0625 and 0.125 µgmL-1, respectively. The recovery value of this method is 101.90% and the reproducibility is within 2.16.
Conclusion: This is a rapid stability indicating HPLC method for determination of NA and can be applied for determination of NA in presence of other steroids as Levonorgestrel, Estradiol and Norethisterone.
Â
Downloads
References
Hammond GL, Rabe T, Wagner JD. Preclinical profiles of progestins used in formulations of oral contraceptives and hormone replacement therapy. Am J Obstet Gynecol 2001;185:S24-S31.
Swynnerton NF, Fischer JB. Determination of ethynylestradiol and norethindrone in synthetic intestinal fluid and in timed-release oral formulations. J Liq Chromatog 1980;3:1195-204.
Gluck JA, Shek E. Determination of ethinylestradiol and norethisterone in an oral contraceptive capsule by reversed-phase high performance liquid chromatography. J Chromatogr Sci 1980;18:631-6.
Loo JC, Brien R. Analysis of norethindrone in plasma by high-performance liquid chromatography. J Liq Chromatogr 1981;4(5):871-7.
Fayad PB, Prevost M, Sauve S. On-line solid-phase extraction coupled to liquid chromatography tandem mass spectrometry optimized for the analysis of steroid hormones in urban wastewaters. Talanta 2013;115:349–60.
Gonzalo-Lumbreras R, Izquierdo-Hornillos R. High-performance liquid chromatographic optimization study for the separation of natural and synthetic anabolic steroids: Application to urine and pharmaceutical samples. J Chromatogr B 2000;742:1-11.
Boglárka B, Géza R, Mária M, Zoltán V, Katalin FF. OPLC, a method between TLC and HPLC, for purity testing of norethisterone bulk drug substance and tablet. Planar Chromatogr 2003;16:359-62.
Krishna PM, Rao BT, Kumar RK, Venkateswarlu P. Development and validation of method for the determination of related substances of norethindrone in norethindrone tablets and degradation studies. Int J Chem Tech Res 2011;3:143-8.
Ali I, Hussain I, Saleem K, Aboul-Enein HY. Development of efficient SPE–TLC method and evaluation of biological interactions of contraceptives with progesterone receptors. Arabian J Chem 2012;5:235-40.
Fotherby K, Warren RJ, Shrimanker K, Siekmann L, Siekmann A, Breuer H. Plasma levels of norethisterone measured by radioimmunoassay and gas chromatography-mass fragmentography. J Steroid Biochem 1979;10:121-2.
Braselton WE, Lin TJ, Mills TM, Ellegood JO, Mahesh VB. Identification and measurement by gas chromatography-mass spectrometry of norethindrone and metabolites in human urine and blood. J Steroid Biochem 1977;1:9-18.
Braselton WE, Lin TJ, Ellegood JO, Mills TM, Mahesh VB. Accumulation of norethisterone and individual metabolites in human plasma during short-and long-term administration of contraceptive dosage. Am J Obstet Gynecol 1979;133:154-60.
Sahlberg BL, Landgren BM, Axelson M. Metabolic profiles of endogenous and ethynyl steroids in plasma and urine from women during administration of oral contraceptives. J Steroid Biochem 1987;26:609-17.
Stanczy FZ, Roy S. Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids. Contracept 1990;42:67-96.
Rizk MS, Zakhari NA, Walash MI, Toubar SS, Brooks CJ, Anderson R. Gas chromatography and mass spectrometry of dimethylethylsilyl ether derivatives of norethisterone metabolites in plasma. Acta Pharm Nord 1991;4:205-10.
Pommier F, Sioufi A, Godbillon J. Simultaneous determination of norethisterone and six metabolites in human plasma by capillary gas chromatography with mass-selective detection. J Chromatogr B 1995;674:155-65.
Pommier F, Sioufi A, Godbillon J. Quantitative determination of norethisterone acetate in human plasma by capillary gas chromatography with mass-selective detection. J Chromatogr A 1996;750:75-81.
Khattab FI, Ashour FM, Amer MM. Argentometric methods for the determination of acetylenic steroids, ethinyloestradiol and norethisterone. J Pharm Belgique 1983;38:147-55.
Opheim LN. Determination of noretisterone in tablets by differential pulse polarography. Anal Chim Acta 1977;89:225-9.
Chatten LG, Yadav RN, Binnington S, Moskalyk RE. Polarographic study of certain progestogens and their determination in oral contraceptive tablets by differential pulse polarography. Analyst 1977;102:323-7.
Yadav RN, Teare FW. Determination of fluoxymesterone, norethandrolone, prednisolone, and prednisone in tablets by differential pulse polarography. J Pharm Sci 1978;67:436-8.
Ghoneim MM, Abushoffa AM, Moharram YI, El-Desoky HS. Voltammetry and quantification of the contraceptive drug norethisterone in bulk form and pharmaceutical formulation. J Pharm Biomed Anal 2007;43:499-505.
Ayad MM, EL-Henawee MM, Abdellatef HE, EL-Sayed HM. Spectrophotometric determination of levonorgestrel, norethisterone acetate, mometasone furoate and fluticasone propionate using 4-amino-antipyrine. Bull Fac Pharm (Cairo Univ) 2005;43:24-8.